← Case indexCCME
China MediaExpress Holdings (NASDAQ: CCME)
Muddy Waters' February 2011 short, auditor Deloitte's resignation, and the SEC fraud charges that followed.
| Key Fact | Detail |
|---|---|
| Report | Forensic Short — Closed Case |
| Publication date | December 15, 2013 |
| Issuer | China MediaExpress Holdings, Inc. (Cayman / China bus-advertising issuer, listed via reverse merger) |
| Ticker | NASDAQ: CCME (delisted) |
| Original short | Muddy Waters Research — "China MediaExpress: A Fraud" (February 3, 2011) |
| Headline post-publication events | Auditor Deloitte resigns (March 11, 2011); Nasdaq trading halt and delisting; SEC fraud charges against company and executives; permanent bars |
| Rating | SHORT — Closed Case (equity extinguished) |
Why We Are Publishing Today
China MediaExpress Holdings (CCME) is one of the founding cases of the early-2011 wave of US-listed China reverse-merger forensic shorts. The original short publication on CCME — a bus-advertising issuer listed via reverse merger — landed in February 2011 alongside continuing work on Rino International (November 2010). The rapid auditor resignation, Nasdaq delisting, and SEC enforcement that followed established the procedural template subsequent China reverse-merger forensic shorts inherited.
This Closed Case write-up consolidates the public record from the original short publication through the SEC enforcement dispositions.
Section 1 — The Thesis (As Of February 2011)
Our reading of CCME, at the time the issuer was first publicly questioned, identified three core deficiencies:
- Materially overstated revenue in the disclosed inter-city bus advertising operations in China;
- Misrepresented operating-fleet scale of advertising-equipped buses;
- Cash and receivables disclosures that did not match underlying operational substance.
The thesis drew on on-the-ground research methodology developed across the 2010–2011 China-listed-issuer cohort.
Section 2 — Deloitte's Resignation (March 11, 2011)
The post-publication sequence was unusually rapid by the standards of the period:
- February 3, 2011. MW publishes; CCME shares fall sharply.
- March 11, 2011. Auditor Deloitte Touche Tohmatsu publicly resigns as CCME's auditor, citing inability to rely on representations made by management and indications that previously-issued financial statements may have been false.
- March 2011 onward. Nasdaq imposes a trading halt and commences delisting proceedings.
The Deloitte resignation — particularly the auditor's public statement of inability to rely on management representations — was unusually direct for a Big-Four auditor and is among the cleanest public auditor disavowals of any post-2010 forensic-short case.
Section 3 — SEC Charges and Permanent Bars
Through 2013–2015, the SEC pursued civil enforcement:
- 2013. SEC files civil fraud charges against China MediaExpress Holdings, founder and CEO Zheng Cheng, and former CFO Jacky Lam;
- Subsequent dispositions. Default judgments and contested-procedure outcomes resulted in permanent bars against named individuals from serving as officers or directors of US public companies, along with civil money penalties.
Common equity in CCME was effectively zero in subsequent dispositions.
Section 4 — Where Things Stand And What We Take From The Case
As of this writing:
- China MediaExpress Holdings is defunct as a US-listed entity.
- The SEC enforcement actions are substantively closed.
- The case sits in the historical record as one of the founding entries of the 2010–2013 wave of US-listed China reverse-merger forensic shorts.
What we take from the CCME case:
- The Big-Four auditor public disavowal is the cleanest single confirmation signal in the genre. Deloitte's March 2011 resignation statement is the modal post-2010 China-short auditor-confirmation pattern — and where it occurs, it has been a near-conclusive signal for subsequent regulator action.
- Reverse mergers warranted heightened scrutiny in 2010–2013. The cohort of US-listed Chinese issuers that entered the US markets via reverse merger with shell companies — rather than via IPO — was, in retrospect, disproportionately associated with subsequent enforcement actions. The post-CCME PCAOB and SEC regulatory response on China reverse mergers materially adjusted the disclosure baseline.
- MW's 2010–2011 cohort established the procedural template. Together with Sino-Forest (2011), Rino International (2010), and a handful of others, CCME was part of the founding cohort that established the on-the-ground China-research methodology subsequent practitioners adopted.
Source Index (selected)
- Deloitte Touche Tohmatsu — resignation letter / public statement, March 11, 2011.
- Nasdaq — trading halt and delisting notices, 2011.
- US Securities and Exchange Commission — Litigation Release materials, SEC v. China MediaExpress Holdings, Inc., et al.
— Muddy Insights, December 15, 2013.
// More files
- 0282026-10-21CURRCURR · 2026-10-21Currenc Group Inc. (NASDAQ: CURR) — Forensic FileA Charging Order Over The Only Asset That Matters. The Same 100,465 Tranglo Shares Sold For US$400M Are Now Charged To A Judgment Creditor.NOT RATED — Forensic FileNOT RATED — Forensic File
- 0272026-07-21DLXYDLXY · 2026-07-21Delixy Holdings Ltd. (NASDAQ: DLXY) — Forensic Short ReportThe IPO Funded An Exit, Not An Expansion. Dividends Out 4x What The Public Put In.NOT RATED — Research case studyNOT RATED — Research case study
- 0262026-07-15TROOTROO · 2026-07-15TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateThe August 20 Endgame: Winding-Up Exposure, Suspension Mechanics, And A Support Bid Running On FumesSHORT — High convictionSHORT — High conviction
- 0252026-05-15ADANIENTADANIENT · 2026-05-15Adani Enterprises (NSE: ADANIENT)Three years after Hindenburg, two years after OCCRP, eighteen months after the EDNY indictment — what the public record now shows.SHORT — UpdateSHORT — Update
- 0242026-05-05TROOTROO · 2026-05-05TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateAuditor Replaced. Lock-Up Eased. Annual Report Past Due.SHORT — High convictionSHORT — High conviction
- 0232026-04-15TRETRE · 2026-04-15Sino-Forest Corporation (TSX: TRE)The founding case of the modern China-short genre — fifteen years on.SHORT — Closed CaseSHORT — Closed Case
- 0222026-03-30BURBUR · 2026-03-30Burford Capital (NYSE/LSE: BUR)Six years on from Muddy Waters' mismarking thesis — what the Second Circuit's March 2026 reversal of the YPF judgment changes.NEUTRALNEUTRAL
- 0212026-02-25IEPIEP · 2026-02-25Icahn Enterprises L.P. (NASDAQ: IEP)Three years after Hindenburg's "Pied Piper of Pumpland" — distributions, the SEC settlement, and the margin-loan unwind.SHORT — UpdateSHORT — Update
- 0202026-02-01WDIWDI · 2026-02-01Wirecard AG (XETRA: WDI) — Closed-Case RetrospectiveSix years after the €1.9B missing cash — what a streamlined trial, a €140M civil award, and the Marsalek-as-FSB-asset disclosures now confirm.SHORT — Closed CaseSHORT — Closed Case
- 0192026-01-15NKLANKLA · 2026-01-15Nikola Corporation (NASDAQ: NKLA)The Hindenburg short, the Milton conviction, the Trump pardon, and the company's own Chapter 11.SHORT — Closed CaseSHORT — Closed Case
- 0182025-12-02MAGHMAGH · 2025-12-02Magnitude International Ltd. (NASDAQ: MAGH) — Forensic ShortPenny-Priced Pre-IPO Equity, Eight-Month Cashout, Resale Shelf Engineered for Insider Exit.SHORT — High convictionSHORT — High conviction
- 0172025-10-21VRXVRX · 2025-10-21Valeant Pharmaceuticals (NYSE: VRX, now Bausch Health: BHC)Citron's "Pharmaceutical Enron" call, the Philidor disclosure, and the ten-year recovery that never came.SHORT — Closed CaseSHORT — Closed Case
- 0162025-09-01TIOTIO · 2025-09-01Tingo Group (NASDAQ: TIO)Hindenburg's June 2023 short, SEC fraud charges, the $250M civil judgment, and the founder still at large.SHORT — Closed CaseSHORT — Closed Case
- 0152024-09-15EBIXEBIX · 2024-09-15Ebix, Inc. (NASDAQ: EBIX)Hindenburg's June 2021 short, the December 2023 Chapter 11, the $400M Zinnia sale, and the August 2024 emergence under Eraaya LifeSpaces sponsorship.SHORT — UpdateSHORT — Update
- 0142024-07-15FFGRPFFGRP · 2024-07-15Folli Follie (ATHEX: FFGRP)QCM's May 2018 short, the largest stock-market fraud in modern Greek history, and the June 2024 prison sentences.SHORT — Closed CaseSHORT — Closed Case
- 0132024-04-15SNHSNH · 2024-04-15Steinhoff International (JSE: SNH)Viceroy's December 2017 short, €7B+ of confirmed accounting irregularities, and the July 2023 vote to dissolve.SHORT — Closed CaseSHORT — Closed Case
- 0122024-04-01RIDERIDE · 2024-04-01Lordstown Motors (NASDAQ: RIDE, now Nu Ride: NRDE)From SPAC pre-orders to Chapter 11 to a litigation-vehicle reorganization.SHORT — Closed CaseSHORT — Closed Case
- 0112022-09-15GSXGSX · 2022-09-15GSX Techedu (NYSE: GSX, now Gaotu: GOTU)Muddy Waters' May 2020 short, the July 2021 "double reduction" policy that vindicated the broader sector thesis, and the 2022 HFCAA delisting.SHORT — Closed CaseSHORT — Closed Case
- 0102022-05-15EROSEROS · 2022-05-15Eros International / Eros STX Global (NYSE: EROS, formerly)Kerrisdale's November 2015 short, the 2020 merger with STX Entertainment, and the 2022 separation that effectively ended the listed parent.SHORT — Closed CaseSHORT — Closed Case
- 0092021-09-15QPPQPP · 2021-09-15Quindell PLC (LSE AIM: QPP, now Watchstone)Gotham City Research's April 2014 short, the £637M Slater & Gordon sale, the £11M settlement that followed, and the SFO investigation that ended without charge.SHORT — Closed CaseSHORT — Closed Case
- 0082020-10-15SONGSONG · 2020-10-15Akazoo S.A. (NASDAQ: SONG)QCM's April 2020 short, SEC fraud charges, and the fastest US-regulator resolution of a SPAC-era fraud.SHORT — Closed CaseSHORT — Closed Case
- 0072020-02-15INSYINSY · 2020-02-15Insys Therapeutics (NASDAQ: INSY)Citron's August 2016 short, the Subsys opioid-marketing prosecution, the June 2019 bankruptcy, and the first US pharmaceutical-executive RICO conviction for opioid marketing.SHORT — Closed CaseSHORT — Closed Case
- 0062020-01-15ONON · 2020-01-15Bio-on S.p.A. (Borsa Italiana AIM: ON) — Forensic Short Closed CaseAuditor-quality bioplastics revenue, a same-quarter founder arrest, and the fastest closure of any modern European forensic-short case.SHORT — Closed CaseSHORT — Closed Case
- 0052019-01-15N21N21 · 2019-01-15Noble Group (SGX: N21)Iceberg Research's February 2015 short, multi-year mark-to-model contestation, and the 2018 break-up of one of Asia's largest commodity traders.SHORT — Closed CaseSHORT — Closed Case
- 0042018-01-15NQNQ · 2018-01-15NQ Mobile (NYSE: NQ)Muddy Waters' October 2013 short, four years of contested public posture, and the eventual NYSE delisting in 2017.SHORT — Closed CaseSHORT — Closed Case
- 0032015-09-15FMCNFMCN · 2015-09-15Focus Media (NASDAQ: FMCN, formerly)Muddy Waters' November 2011 short, the 2013 take-private at a premium, and the 2015 China A-share relisting at a multiple of the take-private price.SHORT — Counter-CaseSHORT — Counter-Case
- 0022014-08-01GOWGOW · 2014-08-01Let's Gowex (BME MAB: GOW)Gotham City Research's July 2014 short, the CEO confession within days, and the fastest forensic-short to bankruptcy in the modern catalogue.SHORT — Closed CaseSHORT — Closed Case
- 0012013-12-15LFTLFT · 2013-12-15Longtop Financial Technologies (NYSE: LFT)Citron's April 2011 short, Deloitte's May 2011 resignation letter, and the SEC's signature fraud case of the 2011 China-short wave.SHORT — Closed CaseSHORT — Closed Case